India's growing prominence as a destination for clinical trials has highlighted the need for increased public awareness, according to GlobalData, a data and analytics company. Despite a rise in clinical trials initiated by both domestic and multinational pharmaceutical companies in India, the general public remains largely unaware of these trials.
The report suggests that raising awareness could benefit pharma companies and contract research organizations by diversifying trials and attracting a larger pool of participants. The lack of clinical trial awareness campaigns by pharma companies in India has been identified as a concern, with the report encouraging the use of strategic approaches and partnerships with medical institutions and local governments to educate patients about the benefits of participating in trials. Increased awareness is expected to dispel misconceptions, facilitate access to new treatments, and have a positive impact on the health sector.
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
Please login to comment on this article